News
8h
Medpage Today on MSNNovel Vaccine Shows Promise in Pancreatic Cancer
An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...
Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...
7h
GlobalData on MSNElicio’s peptide cancer vaccine shows survival benefit in Phase I trial
The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...
Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.
A new pancreatic cancer vaccine has appeared to slow disease progression and increase survival for patients in an early trial ...
The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.
A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal ...
Oregon Health & Science University said a trained AI program can detect cancer of a larynx by picking up the distinct ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.
Cover Media US on MSN13h
New Pancreatic Cancer Vaccine Shows Promise in Early Trial, Offering Fresh Hope for Patients
A new vaccine for pancreatic cancer has shown potential in early trials, slowing disease progression and increasing survival rates. The vaccine was tested in a phase 1 trial involving 20 pancreatic ...
It ain’t what you don’t know that gets you into trouble. It’s what you know for sure that just ain’t so.” Mark Twain’s quip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results